Plasma interleukin-1 beta concentrations in panic disorder

Francesca Brambilla, Laura Bellodi, Giampaolo Perna, Angelo Bertani, Alberto Panerai, Paola Sacerdote

Research output: Contribution to journalArticlepeer-review


Plasma interleukin-1β (IL-1β) concentrations were measured in 10 outpatients with panic disorder before and on days 30 and 32 of treatment with alprazolam (2-2.5 mg/day). IL-1β concentrations were found to be significantly higher in patients than in control subjects both before and during therapy. Thus, IL-1β levels may be a marker of panic disorder that is not related to the current level of symptomatology.

Original languageEnglish
Pages (from-to)135-142
Number of pages8
JournalPsychiatry Research
Issue number2
Publication statusPublished - 1994


  • alprazolam
  • Anxiety
  • psychoimmunology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)


Dive into the research topics of 'Plasma interleukin-1 beta concentrations in panic disorder'. Together they form a unique fingerprint.

Cite this